|
Variable
|
No. of cases (%)
|
|---|
|
Gender
|
|
Female
|
468 (39.6)
|
|
Male
|
715 (60.4)
|
|
Age (years)
|
|
≤50
|
564 (47.7)
|
|
>50
|
619 (52.3)
|
|
Tumor functionality
|
|
Nonfunctional
|
979 (82.8)
|
|
Functional
|
204 (17.2)
|
|
Tumor location
|
|
Stomach
|
245 (20.7)
|
|
Pancreas
|
332 (28.1)
|
|
Small intestine
|
85 (7.2)
|
|
Appendix
|
40 (3.4)
|
|
Colon
|
39 (3.3)
|
|
Rectum
|
442 (37.4)
|
|
Tumor size (cm)
|
|
<2.0
|
616 (52.1)
|
|
2.0–4.0
|
272 (23.0)
|
|
>4.0
|
295 (24.9)
|
|
Grade (WHO 2010 classification)
|
|
G1
|
608 (51.4)
|
|
G2
|
270 (22.8)
|
|
G3
|
305 (25.8)
|
|
Tumor type
|
|
NET
|
881 (74.5)
|
|
NEC
|
261 (22.1)
|
|
MANEC
|
41 (3.5)
|
|
T category (ENETS criteria)
|
|
T1
|
510 (43.1)
|
|
T2
|
220 (18.6)
|
|
T3
|
314 (26.5)
|
|
T4
|
139 (11.7)
|
|
N category (ENETS criteria)
|
|
N0
|
846 (71.5)
|
|
N1
|
337 (28.5)
|
|
M category (ENETS criteria)
|
|
M0
|
925 (78.2)
|
|
M1
|
258 (21.8)
|
|
TNM stage (ENETS criteria)
|
|
I
|
479 (40.5)
|
|
II
|
246 (20.8)
|
|
III
|
200 (16.9)
|
|
IV
|
258 (21.8)
|
|
Surgery
|
|
Yes
|
1016 (85.9)
|
|
No
|
167 (14.1)
|
-
WHO World Health Organization, NET neuroendocrine tumor, NEC neuroendocrine carcinoma, MANEC mixed adenoneuroendocrine carcinoma, ENETS European Neuroendocrine Tumor Society
